117 related articles for article (PubMed ID: 22153829)
1. Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.
Taira T; Ishii G; Nagai K; Yoh K; Takahashi Y; Matsumura Y; Kojima M; Ohmatsu H; Goto K; Niho S; Takashima H; Inoue H; Ohe Y; Ochiai A
Lung Cancer; 2012 Jun; 76(3):423-30. PubMed ID: 22153829
[TBL] [Abstract][Full Text] [Related]
2. Low podoplanin expression of tumor cells predicts poor prognosis in pathological stage IB squamous cell carcinoma of the lung, tissue microarray analysis of 136 patients using 24 antibodies.
Ito T; Ishii G; Nagai K; Nagano T; Kojika M; Murata Y; Atsumi N; Nishiwaki Y; Miyazaki E; Kumamoto T; Ochiai A
Lung Cancer; 2009 Mar; 63(3):418-24. PubMed ID: 18657337
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
[TBL] [Abstract][Full Text] [Related]
4. Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.
Takahashi Y; Ishii G; Taira T; Fujii S; Yanagi S; Hishida T; Yoshida J; Nishimura M; Nomori H; Nagai K; Ochiai A
J Thorac Oncol; 2011 Sep; 6(9):1460-7. PubMed ID: 21849853
[TBL] [Abstract][Full Text] [Related]
5. Laminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma.
Masuda R; Kijima H; Imamura N; Aruga N; Nakazato K; Oiwa K; Nakano T; Watanabe H; Ikoma Y; Tanaka M; Inokuchi S; Iwazaki M
Biomed Res; 2012; 33(5):309-17. PubMed ID: 23124251
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.
Li J; Chen H; Li X; Wang L; Gao A; Zhang P; Lin W; Gao W; Yang D; Guo X; Liu J; Dang Q; Sun Y
Mol Med Rep; 2017 Aug; 16(2):1643-1652. PubMed ID: 28656229
[TBL] [Abstract][Full Text] [Related]
9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
11. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
12. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
[TBL] [Abstract][Full Text] [Related]
15. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
18. Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.
Soria JC; Moon C; Kemp BL; Liu DD; Feng L; Tang X; Chang YS; Mao L; Khuri FR
Clin Cancer Res; 2003 May; 9(5):1785-91. PubMed ID: 12738735
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
Qiao GB; Wu YL; Ou W; Yang XN; Zhong WZ; Lin JY; Zhao J; Xie D; Guan XY
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(14):913-7. PubMed ID: 16083620
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]